3meg
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
| - | [[Image:3meg. | + | [[Image:3meg.png|left|200px]] |
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===HIV-1 K103N Reverse Transcriptase in Complex with TMC278=== | ===HIV-1 K103N Reverse Transcriptase in Complex with TMC278=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_20438081}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 20438081 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_20438081}} | ||
==About this Structure== | ==About this Structure== | ||
3MEG is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Hiv-1_m:b_hxb2r Hiv-1 m:b_hxb2r]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3MEG OCA]. | 3MEG is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Hiv-1_m:b_hxb2r Hiv-1 m:b_hxb2r]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3MEG OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:20438081</ref><references group="xtra"/> | ||
[[Category: Hiv-1 m:b_hxb2r]] | [[Category: Hiv-1 m:b_hxb2r]] | ||
[[Category: RNA-directed DNA polymerase]] | [[Category: RNA-directed DNA polymerase]] | ||
| Line 25: | Line 34: | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu May 20 09:08:10 2010'' |
Revision as of 06:08, 20 May 2010
HIV-1 K103N Reverse Transcriptase in Complex with TMC278
Template:ABSTRACT PUBMED 20438081
About this Structure
3MEG is a 2 chains structure with sequences from Hiv-1 m:b_hxb2r. Full crystallographic information is available from OCA.
Reference
- Lansdon EB, Brendza KM, Hung M, Wang R, Mukund S, Jin D, Birkus G, Kutty N, Liu X. Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design. J Med Chem. 2010 May 3. PMID:20438081 doi:10.1021/jm1002233
Page seeded by OCA on Thu May 20 09:08:10 2010
